Gulek Bozkurt, Arslan Muhammet, Sozutok Sinan
Dr. Bozkurt Gulek Department of Radiology, Faculty of Medicine, University of Health Sciences, Adana, Turkey.
Dr. Muhammet Arslan Department of Radiology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
Pak J Med Sci. 2018 Nov-Dec;34(6):1332-1335. doi: 10.12669/pjms.346.15683.
To assess the value of endovenous laser ablation (EVLA) for treating great saphenous vein (GSV) incompetence.
We reviewed the overall results of EVLA procedures performed on 554 patients in our clinic between March 2011 and December 2015. Evaluations were made concerning the situations of the great saphenous vein (GSV), the energy used in the treatments, and the results obtained. We also investigated if there was a possibility to detect failure of EVLA treatment at an early stage.
From a total of 657 GSVs that were subjected to EVLA treatment, the procedure was found to be successful for 611 GSVs and unsuccessful for 46 GSVs (success rate: 93%). In 38 of the 46 GSVs, a thrombus formation was detected by color Doppler ultrasonography (CDUS) at the postoperative first month (82.6%).
EVLA is a reliable and successful method utilized for the treatment of GSV incompetence. It is concluded that the detection of a thrombus in the GSV tract during the first postoperative follow-up month is an indicator for revascularization.
评估腔内激光消融术(EVLA)治疗大隐静脉(GSV)功能不全的价值。
我们回顾了2011年3月至2015年12月期间在我院对554例患者进行的EVLA手术的总体结果。对大隐静脉(GSV)的情况、治疗中使用的能量以及获得的结果进行了评估。我们还研究了是否有可能在早期阶段检测到EVLA治疗失败。
在总共657条接受EVLA治疗的大隐静脉中,该手术对611条大隐静脉成功,对46条大隐静脉失败(成功率:93%)。在46条大隐静脉中的38条中,术后第一个月通过彩色多普勒超声(CDUS)检测到血栓形成(82.6%)。
EVLA是一种用于治疗大隐静脉功能不全的可靠且成功的方法。得出结论,术后第一个随访月内在大隐静脉通道中检测到血栓是血管再通的一个指标。